Described herein are pharmaceutical packaging programs which avoid oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate medication, these types of units which includes a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty very low permeability to oxy